Zobrazeno 1 - 10
of 72
pro vyhledávání: '"R, Ozols"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
INTRODUCTION: Anaplastic oligodendrogliomas and anaplastic oligoastrocytomas histologically are considered as grade III tumors. Both these forms are highly sensitive to chemotherapy and tend to have similar responses to complex postoperative therapy.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99feedf82cb8b8fd787b3261136b2c5e
https://europepmc.org/articles/PMC4185697/
https://europepmc.org/articles/PMC4185697/
Publikováno v:
Experimental oncology. 34(2)
Recent technologic advances have led to the development of frameless radiosurgery. We report our initial results using frameless image-guided radiosurgery for the management of brain metastases.Over a 2-year period, 16 patients harboring 28 lesions w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7ead9d040fa91e22b508c813bb0f06cd
https://pubmed.ncbi.nlm.nih.gov/23013766
https://pubmed.ncbi.nlm.nih.gov/23013766
Autor:
R, Ozols
Publikováno v:
Tumori. 85(3 Suppl 1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::55a7f97761d495c1878ea67513fb63a1
https://pubmed.ncbi.nlm.nih.gov/10542879
https://pubmed.ncbi.nlm.nih.gov/10542879
Publikováno v:
Seminars in oncology. 24(4 Suppl 12)
We previously reported a 62% response rate and 54% 1-year survival rate for paclitaxel (Taxol; Bristol-Myers Squibb Company, Princeton, NJ) administered by 24-hour infusion in combination with fixed-dose carboplatin to treat patients with advanced no
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9fe5d0041feafb21096708b8f80c5a7b
https://pubmed.ncbi.nlm.nih.gov/9331128
https://pubmed.ncbi.nlm.nih.gov/9331128
Publikováno v:
Oncology (Williston Park, N.Y.). 10
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fc6c420ff1f6442bea4d6e9af01b8312
https://pubmed.ncbi.nlm.nih.gov/8953610
https://pubmed.ncbi.nlm.nih.gov/8953610
Publikováno v:
Seminars in oncology. 22(3 Suppl 6)
Based on the superior response rates (21% to 24%) of patients treated with single-agent paclitaxel (Taxol; Bristol-Myers Squibb Company, Princeton, NJ) in Eastern Cooperative Oncology Group and M.D. Anderson Cancer Center trials in non-small cell lun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3c89a9b262096142e801b6a44beaa831
https://pubmed.ncbi.nlm.nih.gov/7541156
https://pubmed.ncbi.nlm.nih.gov/7541156
Publikováno v:
Lung Cancer. 18:15-16
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::31770baae669666366f7f7d0cf7f7e54
https://doi.org/10.1016/s0169-5002(97)89328-2
https://doi.org/10.1016/s0169-5002(97)89328-2
Publikováno v:
Journal of Magnetism and Magnetic Materials. 85:303-304
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8d12b74c86fa2b0a34ba12ff77eaf11e
https://doi.org/10.1016/0304-8853(90)90071-w
https://doi.org/10.1016/0304-8853(90)90071-w
Autor:
R OZOLS
Publikováno v:
Current Problems in Cancer. 19:69-69
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0857432b28cc39a5154c5cf8c9ad397d
https://doi.org/10.1016/s0147-0272(07)80003-1
https://doi.org/10.1016/s0147-0272(07)80003-1